Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For over 40 years Drugs has been the definitive journal of drugs and therapeutics, promoting optimum pharmacotherapy by publishing reviews and original research authored by leading international clinicians and researchers to support clinical decision-making.

Through a rigorous and comprehensive program of peer-reviewed evaluations, Drugs provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.

Drugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

Editor
  • Dene Peters
Publishing model
Hybrid. Open Choice – What is this?
Impact
Impact factor: 4.993 (2018)
Five year impact factor: 4.647 (2018)
Speed
Submission to first decision: 36 days
Acceptance to publication: 14 days
Usage
Downloads: 408,043 (2018)

Articles

About this journal

Electronic ISSN
1179-1950
Print ISSN
0012-6667
Abstracted and indexed in
  1. BIOSIS
  2. CAB Abstracts
  3. Chemical Abstracts Service (CAS)
  4. Current Contents/ Life Sciences
  5. Current Contents/Clinical Medicine
  6. EBSCO Discovery Service
  7. EMBASE
  8. EMBiology
  9. EMCare
  10. Elsevier Biobase
  11. Google Scholar
  12. Institute of Scientific and Technical Information of China
  13. Japanese Science and Technology Agency (JST)
  14. Journal Citation Reports/Science Edition
  15. Medline
  16. Naver
  17. OCLC WorldCat Discovery Service
  18. Pathway Studio
  19. ProQuest Agricultural & Environmental Science Database
  20. ProQuest Biological Science Database
  21. ProQuest Biotechnology Research Abstracts
  22. ProQuest British Nursing Database
  23. ProQuest Central
  24. ProQuest Engineering
  25. ProQuest Environmental Science
  26. ProQuest Health & Medical Collection
  27. ProQuest Health Research Premium Collection
  28. ProQuest Materials Science and Engineering Database
  29. ProQuest Medical Database
  30. ProQuest Natural Science Collection
  31. ProQuest Neurosciences Abstracts
  32. ProQuest Nursing & Allied Health Database
  33. ProQuest SciTech Premium Collection
  34. ProQuest Technology Collection
  35. ProQuest Toxicology Abstracts
  36. ProQuest Virology and AIDS Abstracts
  37. ProQuest-ExLibris Primo
  38. ProQuest-ExLibris Summon
  39. Reaxys
  40. SCImago
  41. SCOPUS
  42. Science Citation Index Expanded (SciSearch)
  43. Semantic Scholar
Copyright information

Rights and permissions

Springer Nature policies

© Springer Nature Switzerland AG